These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 10193600)

  • 1. Low-molecular-weight heparin in preventing and treating DVT.
    Rydberg EJ; Westfall JM; Nicholas RA
    Am Fam Physician; 1999 Mar; 59(6):1607-12. PubMed ID: 10193600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-molecular-weight heparin in outpatient treatment of DVT.
    Yeager BF; Matheny SC
    Am Fam Physician; 1999 Feb; 59(4):945-52. PubMed ID: 10068716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of deep vein thrombosis using low-molecular-weight heparins.
    Groce JB
    Am J Manag Care; 2001 Nov; 7(17 Suppl):S510-5; discussion S515-23. PubMed ID: 11732662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
    Hull RD; Pineo GF; Stein P
    Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparin in the treatment of deep venous thrombosis.
    Hauer KE
    West J Med; 1998 Oct; 169(4):240-4. PubMed ID: 9795594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
    Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
    Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug therapy of deep venous thrombosis].
    Bounameaux H
    Ther Umsch; 1996 Apr; 53(4):272-6. PubMed ID: 8658349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW; Agnelli G
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DVT and pulmonary embolism: Part II. Treatment and prevention.
    Ramzi DW; Leeper KV
    Am Fam Physician; 2004 Jun; 69(12):2841-8. PubMed ID: 15222649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment and prevention of venous thromboembolism.
    Hull RD; Pineo GF; Valentine KA
    Semin Thromb Hemost; 1998; 24 Suppl 1():21-31. PubMed ID: 9840689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of venous thromboembolism in high-risk surgical and medical patients.
    Prandoni P; Sabbion P; Tanduo C; Errigo G; Zanon E; Bernardi E
    Semin Vasc Med; 2001; 1(1):61-70. PubMed ID: 15199515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low molecular weight heparin for deep vein thrombosis in glioma patients.
    Schmidt F; Faul C; Dichgans J; Weller M
    J Neurol; 2002 Oct; 249(10):1409-12. PubMed ID: 12382158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin and low-molecular-weight heparin therapy for venous thromboembolism: will unfractionated heparin survive?
    Hull RD; Pineo GF
    Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():11-23. PubMed ID: 15085462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis.
    Cunningham RS
    Semin Oncol; 2006 Apr; 33(2 Suppl 4):S17-25; quiz S41-2. PubMed ID: 16638457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DVT treatment in 2000: state of the art.
    Davidson BL
    Orthopedics; 2000 Jun; 23(6 Suppl):s651-4. PubMed ID: 10875431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of antithrombotic drugs in older people.
    Tufano A; Cerbone AM; Di Minno G
    Minerva Med; 2002 Feb; 93(1):13-26. PubMed ID: 11850611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for low-molecular-weight heparin prophylaxis after total knee arthroplasty.
    Colwell CW; Hardwick ME
    Clin Orthop Relat Res; 2006 Nov; 452():181-5. PubMed ID: 17016231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An outpatient program to treat deep venous thrombosis with low-molecular-weight heparin.
    Pearson SD; Blair R; Halpert A; Eddy E; Mckean S
    Eff Clin Pract; 1999; 2(5):210-7. PubMed ID: 10623053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.